OldLady
Diamond Member
- Nov 16, 2015
- 69,568
- 19,607
- 2,220
We can all find studies by this time that back up our prejudices. When it is all done, they may find it has uses in treatment. Trump jumped the gun with his enthusiasm, but we don't know yet. There ARE studies out there showing it has had positive results IN SOME SITUATIONS. Just like the AIDS epidemic, there was a lot of trial and error finding what worked. But now it has become a chronic condition that can be survived. Do not throw out the baby with the bathwater just because you don't like Trump. That's not sensible.Not true, or just not conclusive?The nationwide study was not a rigorous experiment. But with 368 patients, it’s the largest look so far of hydroxychloroquine with or without the antibiotic azithromycin for COVID-19, which has killed more than 171,000 people as of Tuesday. It's the largest look so far of the drug. Your response talking about "poo", certainly factors in on the uselessness of your post.
Not true.. Over 1/2 the physicians in Spain responded to a survey of 6200 Euro physicians and gave HCQuine the highest rating out of 12 possible drug therapies.. And 368 patients is WAAAY to small and the time frame WAAAY to short to draw ANY final conclusions on as has been explained in this thread and with links...
In fact, the society that publishes the International Journal of Antimicrobial Agents, in which the French study appeared on March 20, denounced the study on April 3, saying it “does not meet the Society’s expected standard, especially relating to the lack of better explanations of the inclusion criteria and the triage of patients to ensure patient safety.”
Furthermore, two subsequent studies conducted in China and France showed nearly opposite results. The French study used hydroxychloroquine and azithromycin to treat 11 patients with severe COVID-19 infections and found “no evidence of rapid antiviral clearance or clinical benefit.” One patient died, two were transferred to intensive care units and one was pulled from the study due to serious complications.
Dr. David Boulware of the University of Minnesota Medical School’s Division of Infectious Diseases and International Medicine is currently running three clinical trials into the drug’s effect on COVID-19.
The first, which launched March 17 and claims to be the first clinical hydroxychloroquine trial into COVID-19 in the U.S., examines prophylactic effects of hydroxychloroquine in exposed patients without symptoms. The second studies the drug’s treatment effects in symptomatic patients, and the third studies prophylaxis in high-risk healthcare workers. You are the typical Trump toad always scrambling to grab that next handful of spaghetti to throw up against the wall.